Literature DB >> 26895574

Trends in thyroid cancer incidence and mortality in Portugal.

Luís Raposo1, Samantha Morais, Maria J Oliveira, Ana P Marques, Maria José Bento, Nuno Lunet.   

Abstract

The objective was to quantify thyroid cancer incidence and mortality trends in Portugal. The number of thyroid cancer cases and incidence rates were retrieved from the Regional Cancer Registries for the period 1989-2011. The number of deaths and mortality rates were obtained from the WHO cancer mortality database (1988-2003 and 2007-2012) and Statistics Portugal (2004-2006; 1988-2012 by region). Joinpoint regression of the standardized incidence and mortality rates was performed. A significant, rapid and continued increase in incidence was observed for both sexes in each of the Regional Cancer Registries, with annual per cent changes (APCs) ranging between 2 and 9. Incidence in Portuguese women is higher than estimates for the world and Europe. Mortality decreased for women (APC: -1.5), with the greatest decrease in the North, and increased marginally for men (APC: +0.2), with a greater increase in the South. The significant increases in incidence in Portugal are predominantly because of the increase in incidence among women from the North. These trends, combined with an overall low mortality and high 5-year relative survival, raise concerns on the extent to which overdiagnosis may be taking place. Further research is needed, quantifying the importance of the most likely determinants of these trends as well as the extent and potentially deleterious effects of overdiagnosis and overtreatment in the Portuguese setting.

Entities:  

Mesh:

Year:  2017        PMID: 26895574     DOI: 10.1097/CEJ.0000000000000229

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  6 in total

1.  USP13 genetics and expression in a family with thyroid cancer.

Authors:  Andrea G Maria; Bruna Azevedo; Nikolaos Settas; Fady Hannah-Shmouni; Constantine A Stratakis; Fabio R Faucz
Journal:  Endocrine       Date:  2022-05-18       Impact factor: 3.925

2.  Circ_0058124 Aggravates the Progression of Papillary Thyroid Carcinoma by Activating LMO4 Expression via Targeting miR-370-3p.

Authors:  Lei Liu; Chaohui Yan; Shudong Tao; Hailing Wang
Journal:  Cancer Manag Res       Date:  2020-10-01       Impact factor: 3.989

3.  Thyroid Cancer Epidemiology in South Spain: a population-based time trend study.

Authors:  Elena Salamanca-Fernández; Miguel Rodriguez-Barranco; Yoe-Ling Chang-Chan; Daniel Redondo-Sánchez; Santiago Domínguez-López; Eloísa Bayo; Dariusz Narankiewicz; José Expósito; María José Sánchez
Journal:  Endocrine       Date:  2018-07-24       Impact factor: 3.633

4.  Genetic Determinants for Prediction of Outcome of Patients with Papillary Thyroid Carcinoma.

Authors:  Antónia Afonso Póvoa; Elisabete Teixeira; Maria Rosa Bella-Cueto; Rui Batista; Ana Pestana; Miguel Melo; Thalita Alves; Mafalda Pinto; Manuel Sobrinho-Simões; Jorge Maciel; Paula Soares
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

5.  Malignancy risk of thyroid nodules: quality assessment of the thyroid ultrasound report.

Authors:  Luís Raposo; Cláudia Freitas; Raquel Martins; Catarina Saraiva; Isabel Manita; Maria João Oliveira; Ana Paula Marques; Bernardo Marques; Gustavo Rocha; Teresa Martins; Teresa Azevedo; Fernando Rodrigues
Journal:  BMC Med Imaging       Date:  2022-04-02       Impact factor: 1.930

6.  Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins.

Authors:  Mardiaty Iryani Abdullah; Ching Chin Lee; Sarni Mat Junit; Khoon Leong Ng; Onn Haji Hashim
Journal:  PeerJ       Date:  2016-09-13       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.